Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Next steps for hypophosphatemic rickets typically involve confirming the diagnosis with blood and urine testing (phosphate, alkaline phosphatase, vitamin D, PTH, and FGF23), X-rays of the legs and wrists, and genetic testing to identify the specific type, followed by referral to endocrinology, nephrology, orthopedics, and dentistry. Management may include oral phosphate with active vitamin D (calcitriol) or FGF23-blocking therapy such as burosumab, plus ongoing monitoring of growth, bone deformity, kidney health, and teeth, and surgery in some cases. Timing, dosing, and specialist choices vary by age, genetic cause, and severity, so there are several important factors to consider before your next appointment. See below to understand more, including warning signs that need prompt attention.
Because bone pain, bowed legs, short stature, dental abscesses, and fatigue overlap with many other conditions, the fastest way to organize your concerns is to run a free, instant, online symptom check that reviews your specific pattern of symptoms in a few minutes. It gives you a clearer sense of possible causes, which specialist to see first, and which questions and tests to raise, so you walk into care prepared rather than guessing.
Last reviewed for medical accuracy: 08/18/2026
Hypophosphatemic rickets is a rare disorder marked by low phosphate levels in the blood, leading to weak or soft bones, bone pain and deformities. Early recognition and prompt management can improve growth, reduce complications and enhance quality of life. Below is a practical guide on what to do next if you suspect or have been diagnosed with hypophosphatemic rickets.
Hypophosphatemic rickets arises from phosphate wasting in the kidneys. Phosphate is vital for bone mineralization. When it’s low:
Most cases are genetic, with X-linked hypophosphatemia (XLH) being the most frequent form. Other types include autosomal dominant and autosomal recessive hypophosphatemic rickets.
Symptoms often appear in infancy or early childhood but can be milder and noticed later. Look for:
If you’re unsure whether your symptoms warrant further evaluation, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help guide your next steps before seeing a healthcare provider.
A pediatrician, family doctor or endocrinologist experienced in metabolic bone disorders can coordinate:
Prompt specialist input ensures accurate diagnosis and early treatment, which is crucial for optimal bone health.
Accurate diagnosis relies on lab tests and imaging:
Treatment aims to raise phosphate levels, promote normal bone mineralization and reduce symptoms. Typical components include:
Frequent follow-up is essential to adjust therapy and avoid complications:
Optimal bone health requires more than medications:
Hypophosphatemic rickets affects more than bones. You may need:
Living with a chronic bone disorder can be challenging. Resources to explore:
While most issues can be managed on an outpatient basis, get immediate medical attention if you experience:
Hypophosphatemic rickets is a lifelong condition. Maintaining regular contact with your healthcare team helps:
Managing hypophosphatemic rickets can feel overwhelming, but a structured approach makes a difference:
If you’re concerned about bone pain, growth delays or unexplained fractures, consider trying a free, online symptom check, using the doctor approved Ubie Symptom Checker. And remember, while online tools can guide you, nothing replaces personalized advice.
Always speak to a doctor about any symptoms that could be life-threatening or seriously impact your health. Early intervention and expert care are key to living well with hypophosphatemic rickets.
(References)
* Baroncelli GI, Toschi B, Bertelloni S. Hypophosphatemic rickets. Curr Opin Endocrinol Diabetes Obes. 2012 Dec;19(6):460-7. doi: 10.1097/MED.0b013e328358be97. PMID: 23108197.
* Haffner D, Emma F, Eastwood DM, Biosse Duplan M, Bacchetta J, Schnabel D, Wicart P, Bockenhauer D, Santos F, Levtchenko E, Harvengt P, Kirchhoff M, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenicky P, Rejnmark L, Linglart A. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2019 Jul;15(7):435-455. doi: 10.1038/s41581-019-0152-5. PMID: 31068690; PMCID: PMC7136170.
* Ackah SA, Imel EA. Approach to Hypophosphatemic Rickets. J Clin Endocrinol Metab. 2022 Dec 17;108(1):209-220. doi: 10.1210/clinem/dgac488. PMID: 35981346; PMCID: PMC9759174.
* Miller WL, Imel EA. Rickets, Vitamin D, and Ca/P Metabolism. Horm Res Paediatr. 2022;95(6):579-592. doi: 10.1159/000527011. Epub 2022 Nov 29. PMID: 36446330.
* Chinoy A, Padidela R. Refractory Rickets. Indian J Pediatr. 2023 Jun;90(6):574-581. doi: 10.1007/s12098-023-04538-4. Epub 2023 Apr 19. PMID: 37074534; PMCID: PMC10212799.
* Kamenický P, Briot K, Munns CF, Linglart A. X-linked hypophosphataemia. Lancet. 2024 Aug 31;404(10455):887-901. doi: 10.1016/S0140-6736(24)01305-9. Epub 2024 Aug 21. PMID: 39181153.
* Haffner D, Emma F, Seefried L, Högler W, Javaid KM, Bockenhauer D, Bacchetta J, Eastwood D, Biosse Duplan M, Schnabel D, Wicart P, Ariceta G, Levtchenko E, Harvengt P, Kirchhoff M, Gardiner O, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenický P, Rejnmark L, Linglart A. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2025 May;21(5):330-354. doi: 10.1038/s41581-024-00926-x. Epub 2025 Jan 15. PMID: 39814982.
* Ali DS, Carpenter TO, Imel EA, Ward LM, Appelman-Dijkstra NM, Chaussain C, Jan de Beur SM, Florenzano P, Abu Alrob H, Aldabagh R, Alexander RT, Alsarraf F, Beck-Nielsen SS, Biosse-Duplan M, Crowley RK, Dandurand K, Filler G, Friedlander L, Fukumoto S, Gagnon C, Goodyer P, Grasemann C, Grimbly C, Hussein S, Javaid MK, Khan S, Khan A, Lehman A, Lems WF, Lewiecki EM, McDonnell C, Mirza RD, Morgante E, Morrison A, Portale AA, Rao C, Rhee Y, Rush ET, Siggelkow H, Tetradis S, Tosi L, Guyatt G, Brandi ML, Khan AA. X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline. J Clin Endocrinol Metab. 2025 Jun 17;110(7):2055-2070. doi: 10.1210/clinem/dgaf093. PMID: 39960858; PMCID: PMC12187519.
* Khan AA, Ali DS, Appelman-Dijkstra NM, Carpenter TO, Chaussain C, Imel EA, Jan de Beur SM, Florenzano P, Abu Alrob H, Aldabagh R, Alexander RT, Alsarraf F, Beck-Nielsen SS, Biosse-Duplan M, Cohen-Solal M, Crowley RK, Dandurand K, Filler G, Friedlander L, Fukumoto S, Gagnon C, Goodyer P, Grasemann C, Grimbly C, Hussein S, Javaid MK, Khan S, Khan A, Lehman A, Lems WF, Lewiecki EM, McDonnell C, Mirza RD, Morgante E, Morrison A, Portale AA, Rhee Y, Rush ET, Siggelkow H, Tetradis S, Tosi L, Ward LM, Guyatt G, Brandi ML. X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice Guideline. J Clin Endocrinol Metab. 2025 Jul 15;110(8):2353-2370. doi: 10.1210/clinem/dgaf170. PMID: 40243526; PMCID: PMC12261105.
* Böckmann I, Haffner D. The Diagnosis and Therapy of XLH. Calcif Tissue Int. 2025 Apr 28;116(1):66. doi: 10.1007/s00223-025-01374-w. Epub 2025 Apr 28. PMID: 40295317; PMCID: PMC12037658.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.